[{"AccountsPayableCurrent_0_Q2_USD":8176000.0,"OperatingLeaseCost_2_Q2_USD":3578000.0,"OperatingLeaseLiability_0_Q2_USD":46922000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":5646000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":41276000.0,"OperatingLeasePayments_2_Q2_USD":4940000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":46334000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.098,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":1227000.0,"OtherAssetsNoncurrent_0_Q2_USD":4774000.0,"OtherCommitmentDueInFourthYear_0_Q2_USD":25000000.0,"OtherCommitmentDueInNextTwelveMonths_0_Q2_USD":20000000.0,"OtherCommitmentDueInSecondYear_0_Q2_USD":13000000.0,"OtherCommitmentDueInThirdYear_0_Q2_USD":18000000.0,"OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear_0_Q2_USD":4000000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-2000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-2000.0,"OtherIntangibleAssetsNet_0_Q2_USD":63655000.0,"OperatingLeaseCost_1_Q2_USD":1874000.0,"OperatingIncomeLoss_2_Q2_USD":-140349000.0,"OperatingIncomeLoss_1_Q2_USD":-70337000.0,"OperatingCostsAndExpenses_2_Q2_USD":172452000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":5555000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":18987000.0,"Liabilities_0_Q2_USD":454640000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":640875000.0,"LiabilitiesCurrent_0_Q2_USD":58248000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":31956000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-74113000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-123760000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-62000.0,"NetIncomeLoss_1_Q2_USD":-72197000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-72197000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-143836000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q2_USD":-72197000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_2_Q2_USD":-143836000.0,"NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1_2_Q2_USD":0.0,"NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_2_Q2_USD":501000.0,"NumberOfReportableSegments_2_Q2_segment":2.0,"OperatingCostsAndExpenses_1_Q2_USD":89141000.0,"NetIncomeLoss_2_Q2_USD":-143836000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-357000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-462000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_2_Q2_USD":0.0,"PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_0_Q2_USD":8000000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":29441000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":56692000.0,"ResearchAndDevelopmentInProcess_2_Q2_USD":0.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q2_USD":3452000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1260478000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":32103000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":18804000.0,"PurchaseObligationDueInThirdYear_0_Q2_USD":30000000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":18511000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":99603000.0,"ShareBasedCompensation_2_Q2_USD":21975000.0,"ShortTermInvestments_0_Q2_USD":168662000.0,"StockholdersEquity_0_Q2_USD":186235000.0,"VariableLeaseCost_1_Q2_USD":348000.0,"VariableLeaseCost_2_Q2_USD":631000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":67051902.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":67462413.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":50598000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":8431000.0,"PurchaseObligationDueInSecondYear_0_Q2_USD":30000000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":21092000.0,"PaymentsForDerivativeInstrumentFinancingActivities_2_Q2_USD":0.0,"PaymentsOfDebtIssuanceCosts_2_Q2_USD":0.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":216000.0,"PaymentsToAcquireIntangibleAssets_2_Q2_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":5016000.0,"PaymentsToAcquireShortTermInvestments_2_Q2_USD":168597000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"PurchaseObligationDueInNextTwelveMonths_0_Q2_USD":30000000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockValue_0_Q2_USD":0.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":12602000.0,"ProceedsFromConvertibleDebt_2_Q2_USD":0.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":21707000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_2_Q2_USD":103000000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_2_Q2_USD":0.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":14715000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":42179000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":67462413.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":8685000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":8262000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-165917000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommonStockSharesAuthorized_0_Q2_shares":190000000.0,"CommonStockSharesIssued_0_Q2_shares":71798624.0,"CommonStockSharesOutstanding_0_Q2_shares":71798624.0,"CommonStockValue_0_Q2_USD":72000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-72199000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-143838000.0,"ContractWithCustomerAssetNet_0_Q2_USD":449000.0,"ContractWithCustomerAssetNetCurrent_0_Q2_USD":125000.0,"ContractWithCustomerAssetNetNoncurrent_0_Q2_USD":324000.0,"ContractWithCustomerLiability_0_Q2_USD":83430000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":9862000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":75113000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":2905000.0,"ConvertibleDebtFairValueDisclosures_0_Q2_USD":337600000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":171086000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":336300000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":167634000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":330714000.0,"AccountsReceivableNetCurrent_0_Q2_USD":641000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":105000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":31405000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":5986000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":21087000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-2000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1446643000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":11368000.0,"ConvertibleLongTermNotesPayable_0_Q2_USD":280003000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":21975000.0,"AmortizationOfFinancingCosts_2_Q2_USD":622000.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":622000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":4181000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":7687000.0,"Assets_0_Q2_USD":640875000.0,"AssetsCurrent_0_Q2_USD":354604000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":2000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":330716000.0,"AmortizationOfFinancingCosts_1_Q2_USD":312000.0,"CostOfGoodsAndServicesSoldAmortization_1_Q2_USD":3676000.0,"CostOfGoodsAndServicesSoldAmortization_2_Q2_USD":6514000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":9284000.0,"IncreaseDecreaseInInventories_2_Q2_USD":-811000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":3440000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":3309000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q2_USD":78534000.0,"IntangibleAssetsNetIncludingGoodwill_0_Q2_USD":63655000.0,"InterestExpense_1_Q2_USD":1569000.0,"InterestExpense_2_Q2_USD":3129000.0,"InterestExpenseDebt_1_Q2_USD":1569000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-170000.0,"InterestExpenseDebt_2_Q2_USD":3137000.0,"InterestExpenseDebtExcludingAmortization_2_Q2_USD":2515000.0,"InterestPayableCurrent_0_Q2_USD":1887000.0,"InventoryNet_0_Q2_USD":5065000.0,"InvestmentIncomeNonoperating_1_Q2_USD":85000.0,"InvestmentIncomeNonoperating_2_Q2_USD":182000.0,"LeaseCost_1_Q2_USD":2222000.0,"LeaseCost_2_Q2_USD":4209000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":65909000.0,"InterestExpenseDebtExcludingAmortization_1_Q2_USD":1257000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":8943000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":-1389000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-4090000.0,"DerivativeLiabilitiesCurrent_0_Q2_USD":3159000.0,"EarningsPerShareBasic_1_Q2_USD":-1.07,"EarningsPerShareBasic_2_Q2_USD":-2.15,"EarningsPerShareDiluted_2_Q2_USD":-2.15,"EarningsPerShareDiluted_1_Q2_USD":-1.07,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":19555000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":14879000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":16625000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-1188000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":8320000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":10837000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":16625000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":63655000.0,"Goodwill_0_Q2_USD":146964000.0,"IncomeLossAttributableToParent_1_Q2_USD":-72197000.0,"IncomeLossAttributableToParent_2_Q2_USD":-143836000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":0.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":5967000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":67051902.0,"Ticker":"RVNC","CIK":"1479290","name":"REVANCE THERAPEUTICS, INC.","OfficialName":"Revance Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1265045755.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210805"}]